FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1177187001: Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug)


Status: current, Defined. Date: 31-Oct 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4644003019 Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core
4644004013 Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial en Synonym Active Case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial Is a Clavulanic acid and ticarcillin only product in parenteral dose form true Inferred relationship Some
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial Has manufactured dose form Powder for solution for injection true Inferred relationship Some
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial Has unit of presentation Vial true Inferred relationship Some
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial Plays role Antibacterial therapeutic role true Inferred relationship Some
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial Has precise active ingredient Ticarcillin sodium true Inferred relationship Some 1
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial Has BoSS Ticarcillin true Inferred relationship Some 1
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial Has presentation strength numerator unit g true Inferred relationship Some 1
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial Has presentation strength denominator unit Vial true Inferred relationship Some 1
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial Has precise active ingredient Clavulanate potassium true Inferred relationship Some 2
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial Has BoSS Clavulanic acid true Inferred relationship Some 2
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial Has presentation strength numerator unit mg true Inferred relationship Some 2
Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial Has presentation strength denominator unit Vial true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start